Nucleate’s Post

Nucleate reposted this

View profile for Chandra Ramanathan, graphic

External R&D | Global Head Open Innovation | Board Member | Passionate about Accelerating the Translation of Science and Technology to Impact Patients

Congratulations to the Nucleate team on the impactful first 5 years fostering the next generation of biotech entrepreneurs. Thanks to Soufiane Aboulhouda Oliver Dodd Samantha Sison, Gabriel Manzanarez, Inga Van den Bossche, @Sarah Chong, Hannah Dayton, PhD and other Nucleate team members around the globe.

View organization page for Nucleate, graphic

23,570 followers

We are thrilled to announce the release of our first Impact Report: 5 Years of Nucleate! 📈 This is the story and data behind Nucleate: how we started, expanded globally, and most importantly, the impact made through our unique high-quality initiatives - created and driven by our academic trainee leaders with the support of our partners. During the first 5 years of Nucleate’s existence, the organization rapidly grew from a student-led program at the Harvard Biotech Club to a global 501(c)(3) non-profit with 41 chapters across 20+ countries, operating 15 programs that have empowered over 255 teams globally to raise $370M in funds. We cover: 🔸Nucleate as a global organization 🔸The Activator Program 🔸Our Professional Development Courses 🔸Programs with Partners 🔸The Summit (join us at the 2024 summit this year for more!) 🔸And the fabulous volunteer leaders that make it all happen We hope you find it as enjoyable to read as we did to create it ✨ -The Research Team, Nucleate HQ (Inga Van den Bossche, Sarah C., Gabriel Manzanarez, Samantha Sison) 📄Read more about the 2019-2023 Impact Report here: https://lnkd.in/gVidm3k2 ⬇️Download the 2019-2023 Impact Report Now! impact.nucleate.org Thank you to: ▫️ Our partners—Alnylam Pharmaceuticals, BlueYard Capital, Eli Lilly and Company, Genentech, Lyda Hill Philanthropies, and Pillar VC—for enabling our awesome partnership programs. ▫️ Our global sponsors—Eli Lilly and Company, Genentech, Pillar VC, Alnylam Pharmaceuticals, BlueYard Capital, MilliporeSigma, Excedr, Biocom California, Breakout Ventures, Schrödinger, Cromatic, Sanofi, PHC Corporation of North America, Molecule, Schmidt Futures, and Lyda Hill Philanthropies—for the incredible journey we have gone on together so far. ▫️ Our dedicated board members—Soufiane Aboulhouda, Oliver Dodd, Marissa Pettit Jones, Sofia Guerra, Matthew Lanchantin, Chandra Ramanathan, Ann DeWitt, John Maraganore, Mandi Williams, Mira Chaurushiya, Peter Barrett, Tony Kulesa, Travis McCready, and past and current presidents Michael Retchin, Samantha Sison, Heer Joisher, and Zach Cogan—for their vision, energy, and drive in growing the organization to where it is today. Read more about the Research Initiative here: www.nucleate.org/research Want to get involved? ▫️Apply to the 2024-2025 Activator cohort: apply.nucleate.org ▫️Signup as mentor/expert for the new cohort: mentor.nucleate.org ▫️Become a member of our leadership team: join.nucleate.org

  • No alternative text description for this image
Oliver Dodd

Co-Founder @ Nucleate, PhD Candidate @ Church Lab

2mo

Thank you Chandra Ramanathan for your sage wisdom and tireless support! Can't wait to see what the next 5 years has in store!

Samantha Sison

‘23-‘24 Co-President, Nucleate. PhD Candidate, Yeo Lab.

2mo

Thank you Chandra Ramanathan for all of your support of Nucleate over the years!

Gabriel Manzanarez, Ph.D.

NDSEG Fellow, Systems and Synthetic Biology @ Terence Hwa Lab | EVP Research, Nucleate | Venture Fellow, Climate Capital Bio

2mo

Thank you for your expert guidance Chandra Ramanathan!

See more comments

To view or add a comment, sign in

Explore topics